Range Low Price High Price Comment
30 days $0.102 $0.102 Wednesday, 2nd Dec 2020 AKAO stock ended at $0.102. During the day the stock fluctuated 0% from a day low at $0.102 to a day high of $0.102.
90 days $0.102 $0.102
52 weeks $0.102 $0.102

Historical Achaogen prices

Date Open High Low Close Volume
Oct 31, 2016 $4.59 $4.59 $4.59 $4.59 242 000
Oct 28, 2016 $4.50 $4.50 $4.50 $4.50 658 800
Oct 27, 2016 $4.98 $4.98 $4.98 $4.98 630 100
Oct 26, 2016 $5.73 $5.73 $5.73 $5.73 400 500
Oct 25, 2016 $5.54 $5.54 $5.54 $5.54 398 900
Oct 24, 2016 $5.31 $5.31 $5.31 $5.31 171 700
Oct 21, 2016 $5.49 $5.49 $5.49 $5.49 239 100
Oct 20, 2016 $5.21 $5.21 $5.21 $5.21 119 500
Oct 19, 2016 $5.14 $5.14 $5.14 $5.14 278 200
Oct 18, 2016 $5.13 $5.13 $5.13 $5.13 147 600
Oct 17, 2016 $5.15 $5.15 $5.15 $5.15 443 800
Oct 14, 2016 $4.93 $4.93 $4.93 $4.93 301 200
Oct 13, 2016 $4.92 $4.92 $4.92 $4.92 332 100
Oct 12, 2016 $4.92 $4.92 $4.92 $4.92 145 200
Oct 11, 2016 $5.03 $5.03 $5.03 $5.03 132 700
Oct 10, 2016 $5.20 $5.20 $5.20 $5.20 260 500
Oct 07, 2016 $4.87 $4.87 $4.87 $4.87 72 500
Oct 06, 2016 $4.92 $4.92 $4.92 $4.92 123 700
Oct 05, 2016 $4.92 $4.92 $4.92 $4.92 232 300
Oct 04, 2016 $4.95 $4.95 $4.95 $4.95 166 300
Oct 03, 2016 $4.96 $4.96 $4.96 $4.96 203 100
Sep 30, 2016 $4.79 $4.79 $4.79 $4.79 720 800
Sep 29, 2016 $4.56 $4.56 $4.56 $4.56 162 800
Sep 28, 2016 $4.41 $4.41 $4.41 $4.41 164 200
Sep 27, 2016 $4.34 $4.34 $4.34 $4.34 162 600
Click to get the best stock tips daily for free!

About Achaogen

Achaogen, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes antibacterials to treat multi-drug resistant (MDR) gram-negative infections in the United States. The company is principally developing plazomicin, which is in Phase III clinical trial for the treatment of serious bacterial infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae. It is also involved in the resear... AKAO Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT